Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Crumpacker

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Seminars in Dermatology|June 1, 1996
The pharmacological profile of famciclovirC Crumpacker
Journal of Virology|May 1, 1987
Functional expression of a cloned herpes simplex virus type 1 DNA polymerase geneD Dorsky, P Chatis, C Crumpacker
Virology|August 1, 1985
Inhibition of HSV-transformed murine cells by nucleoside analogs, 2'-NDG and 2'-nor-cGMP: mechanisms of inhibition and reversal by exogenous nucleosidesS Oliver, G Bubley, C Crumpacker
Journal of Acquired Immune Deficiency Syndromes|December 1, 1992
Inhibition of HIV-1 RNA production by the diphtheria toxin-related IL-2 fusion proteins DAB486IL-2 and DAB389IL-2L Zhang, C Waters, J Nichols, et al.
Cancer Research|January 1, 1984
Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenineD Kufe, D Herrick, C Crumpacker, et al.
Journal of Virology|September 1, 1981
Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzymeK W Knopf, E R Kaufman, C Crumpacker
Virology|September 1, 1983
Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cellsG Bubley, C Crumpacker, E De Clercq, et al.
Gene Therapy|May 7, 2005
Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cellsJ Zhang, E Attar, K Cohen, et al.
The Journal of Clinical Investigation|June 1, 1991
Inhibition of immune functions by antiviral drugsW Heagy, C Crumpacker, P A Lopez, et al.
The American Review of Respiratory Disease|February 1, 1983
Treatment of murine cytomegalovirus pneumonia with acyclovir and interferonR M Rose, C Crumpacker, J L Waner, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Seminars in Dermatology|June 1, 1996
The pharmacological profile of famciclovirC Crumpacker
Journal of Virology|May 1, 1987
Functional expression of a cloned herpes simplex virus type 1 DNA polymerase geneD Dorsky, P Chatis, C Crumpacker
Virology|August 1, 1985
Inhibition of HSV-transformed murine cells by nucleoside analogs, 2'-NDG and 2'-nor-cGMP: mechanisms of inhibition and reversal by exogenous nucleosidesS Oliver, G Bubley, C Crumpacker
Journal of Acquired Immune Deficiency Syndromes|December 1, 1992
Inhibition of HIV-1 RNA production by the diphtheria toxin-related IL-2 fusion proteins DAB486IL-2 and DAB389IL-2L Zhang, C Waters, J Nichols, et al.
Cancer Research|January 1, 1984
Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenineD Kufe, D Herrick, C Crumpacker, et al.
Journal of Virology|September 1, 1981
Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzymeK W Knopf, E R Kaufman, C Crumpacker
Virology|September 1, 1983
Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cellsG Bubley, C Crumpacker, E De Clercq, et al.
Gene Therapy|May 7, 2005
Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cellsJ Zhang, E Attar, K Cohen, et al.
The Journal of Clinical Investigation|June 1, 1991
Inhibition of immune functions by antiviral drugsW Heagy, C Crumpacker, P A Lopez, et al.
The American Review of Respiratory Disease|February 1, 1983
Treatment of murine cytomegalovirus pneumonia with acyclovir and interferonR M Rose, C Crumpacker, J L Waner, et al.
Pageof 3